The present invention relates to the use of a composition comprising a fixed combination of a) formoterol, a pharmaceutically acceptable salt or solvate thereof or a solvate of such a salt； and b) beclomethasone dipropionate； for the manufacture of a medicament for use in the prevention or treatment of an acute condition of asthma, intermittent asthma and/or episodes in chronic asthma, more preferably in the rescue treatment of asthma, and in particular in case of acute exacerbations during the maintenance therapy of asthma.
